Tuesday, October 11, 2022 8:40:40 AM
Favre was the “largest individual outside investor and holder of corporate stock” in Prevacus, according to the state’s lawsuit. The former quarterback also at times served as spokesperson for a concussion drug it was manufacturing.
The state’s civil lawsuit alleges that in 2018, Favre encouraged Prevacus CEO Jacob VanLandingham to “solicit (nonprofit founder) Nancy New to use MDHS grant proceeds to invest in the stock of Prevacus.” New has already been criminally convicted in the scheme and agreed to cooperate with authorities in ongoing investigations.
Over the next year, more than $2 million in welfare funds was diverted to the company “for the purpose of securing ‘clinical trial sites’ to be located within Mississippi in order to promote an experimental anti-concussion drug” but, according to the state’s lawsuit, was instead used to buy stock in Prevacus for the people involved in the scheme.
https://share.newsbreak.com/1yzzwe4p
Dear Wall Street,
I am sorry, but you can't take my money.
Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives. • MSRM • Jun 5, 2024 1:32 PM
Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology • HYDI • Jun 5, 2024 10:24 AM
Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation • HLYK • Jun 5, 2024 8:00 AM
Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered Servers • AVAI • Jun 5, 2024 8:00 AM
IQST - iQSTEL Announces $290 Million 2024 Annual Revenue Forecast • IQST • Jun 4, 2024 1:43 PM
ECGI Holdings Accelerates Strategic Initiatives by Securing First of Two $125,000 Convertible Notes • ECGI • Jun 4, 2024 12:15 PM